DNA beats Street, ups guidance

Genentech (DNA) reported third quarter non-GAAP EPS of $0.24, beating by $0.03 the consensus estimate of $0.21 and up 71% from EPS of $0.14 in the

Read the full 263 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE